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Abstract 17 
Purpose: The aim of the work is to compare the biological activity of carbonic nano-18 
structures of natural and artificial origination, namely, humic substances (HS) and fullerenols.  19 
Materials and methods: The representative of the fullerenol group, С60Оy(OH)x where у=2–20 
4, х=22–24, was chosen. Enzyme-based luminescent bioassay was applied to evaluate toxicity 21 
and antioxidant properties of HS and fullerenol; chemiluminescent lumonol method was used 22 
to study a content of reactive oxygen species (ROS) in the solutions. Toxicity of the bioactive 23 
compounds was evaluated using effective concentrations ЕС50; detoxification coefficients 24 
DOxT were applied to study and compare antioxidant activity of the compounds. Antioxidant 25 
activity and ranges of active concentrations of the bioactive compounds were determined in 26 
model solutions of organic and inorganic oxidizers – 1,4-benzoquinone and potassium 27 
ferricianide. 28 
Results and discussion: Values of ЕС50 revealed higher toxicity of HS than fullerenol (0.005 29 
and 0.108 g L-1, respectively); detoxifying concentrations of fullerenol were found to be 30 
lower. Antioxidant ability of HS was demonstrated to be time-dependent; the 50-min 31 
preliminary incubation in oxidizer solutions was suggested as optimal for the detoxification 32 
procedure. On the contrary, fullerenol’ antioxidant effect demonstrated independency on time. 33 
Antioxidant effect of HS did not depend on amphiphilic characteristics of the media (values 34 
of DOxT were 1.3 in the solutions of organic and inorganic oxidizers), while this of fullerenol 35 
was found to depend: it was maximal (DOxT = 2.0) in solutions of organic oxidizer (1,4-36 
benzoquinone).  37 
Conclusions: Both HS and fullerenol demonstrated toxic and antioxidant effects; however 38 
quantitative characteristics of these effects were different. The difference in toxicities was 39 
explained with (1) flexibility of fragments of HS, (2) their higher ability to decrease ROS 40 
content. The difference in antioxidant activity was attributed to flexibility of HS 41 
macromolecules. The paper demonstrates a high potential of luminescent enzymatic bioassay 42 
to study biological activity of nano-structures of natural and artificial origination.  43 
 44 
Keywords  Antioxidant activity • Bioactive compounds • Fullerenol • Humic substances • 45 
Toxicity • Reactive oxygen species 46 
 47 
Abbreviations 48 
HS: humic substances; 49 
F: fullerenol С60Оy(OH)x, where у=2–4, х=22–24; 50 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
3 
 
NADH: nicotinamide adenine dinucleotide disodium salt reduced; 51 
FMN: flavinmononucleotide; 52 
OxT: oxidative toxicity  53 
ROS: reactive oxygen species 54 
 55 
 56 
 57 
1 Introduction 58 
Biological activity of carbonic nano-objects is of great current interest for modern fields of 59 
medicine, biotechnology, pharmacology, and ecology. Biological activity presupposes that 60 
high-dose exposures inhibit physiological functions of organisms (toxic effect), but lower-61 
dose exposures might activate physiological functions as a result of optimization of metabolic 62 
processes. Comparison of biological activity of natural or artificial ‘nano-objects’ is an 63 
important subject in biomedical investigations. Humic substances (HS) and fullerene 64 
derivatives can serve as representatives of carbonic structures of natural and artificial 65 
origination, respectively. 66 
HS are natural bioactive compounds, which are able to attenuate environmental toxicity. HS 67 
are supposed to be irregular polymers of a complex structure (Orlov 1997; Perminova et al. 68 
2001). Another concept is a supramolecular one; it assumes that HS ‘consist of relatively 69 
small molecules linked by hydrogen, hydrophobic, or π-π bonds, as well as polyvalent 70 
cations’ (Piccolo 2001; Richard et al. 2009; Trubetskoj et al. 2009; Lipczynska-Kochany 71 
2018). Both conceptions assume that HS involve different functional groups, which can 72 
provide interactions with toxic compounds in water media, decreasing, by this, an aquatic 73 
toxicity. Mechanisms of these interactions include ion exchange, complexation, redox 74 
transformations, hydrophobic binding, coagulation, peptization, etc (Perelomov et al. 2018). 75 
Direct polar and non-polar interactions of HS with components of biological assay systems 76 
(cells, water-soluble biological compounds of low and high molecular weight) contribute to 77 
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biological effect of HS (Tarasova et al. 2011; Tarasova et al. 2012; Kudryasheva and 78 
Tarasova 2015; Tarasova et al. 2015). HS can take part in physical and chemical membrane 79 
irritation or stimulation through the enhanced surfactant-like interactions (Lipczynska-80 
Kochany 2018). Because of the low molecular masses of their building blocks, HS are 81 
capable to pass bio-membranes, be metabolized intracellularly like xenobiotics, affect the 82 
enzymes, and stimulate oxidative stress defense.  83 
Current paper compares the properties of HS and artificial bioactive compound, fullerenol (F), 84 
water-soluble polyhydroxylated derivative of fullerene-60, rigid nanosize carbonic particle. It 85 
is known that fullerenols are electron deficient structures; this property makes them as 86 
efficient catalyzers in biochemical reactions, and hence, perspective pharmaceutical agents. 87 
Additionally, fullerenols are amphiphilic structures: ‘hydroxyl groups provide them with 88 
aqueous solubility, while the fragments of fullerene skeleton – with affinity to hydrophobic 89 
enzymatic fragments and lipid structures of cellular membranes’ (Foley et al. 2002; 90 
Grebowski et al. 2013). 91 
Luminescence bioassay systems are convenient tools to compare toxic and detoxifying 92 
properties of bioactive compounds; their main advantage is a high rate of registration of the 93 
biological response. This advantage provides possibility to carry out a lot of experiments 94 
under comparable conditions and, hence, an adequate statistical processing. This advantage is 95 
very important for biological analyses which are usually characterized by lower 96 
reproducibility than chemical assays. Luminous marine bacteria (Girotti et al. 2008) and their 97 
enzyme reactions (Kratasyuk and Esimbekova 2015) are among the most useful luminescence 98 
bioassays. They are considered as bioassays of different structural levels (cellular and 99 
enzymatic) and provide microbiological and biochemical analysis of the toxic effects, 100 
respectively. 101 
The enzymatic luminescence bioassay provides monitoring of Oxidative Toxicity (OxT), 102 
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additionally to the conventional general toxicity. The OxT is attributed to redox characteristics 103 
of media (Kudryasheva and Tarasova, 2015). Using the bioluminescent enzymatic assay, the 104 
OxT of organic and inorganic oxidizer’ solutions, quinones and polyvalent metals, have been 105 
previously studied (Kudryasheva et al. 2002; Vetrova et al. 2007; Tarasova et al. 2011); the 106 
importance of amphiphilic property of the organic oxidizers was shown in these studies. 107 
Bioluminescence assays were previously adapted for monitoring changes of OxT under 108 
exposure to bioactive compounds in (Tarasova et al. 2012; Kudryasheva and Tarasova 2015; 109 
Tarasova et al. 2015; Kudryasheva et al. 2017; Sachkova et al. 2017). 110 
The aim of the work is to compare the biological activity of carbonic nano-structures of 111 
natural and artificial origination, namely, HS and fullerenol (F). Difference in rigidity of these 112 
structures is taken into consideration. The representative of the fullerenol group, fullerenol of 113 
lowest toxicity, С60Оy(OH)x where у=2–4, х=22–24 (Eropkin et al. 2013; Kudryasheva et al. 114 
2017; Sachkova et al. 2017) was chosen in this study. Section 3.1 presents toxicity evaluation 115 
of HS and F using enzyme-based luminescent bioassay; a role of reactive oxygen species in 116 
the toxic effects of HS and F is evaluated using chemiluminescent luminol method. Section 117 
3.2 studies antioxidant effect of HS and F in model solutions of organic and inorganic 118 
oxidizers. 119 
 120 
2 Materials and methods 121 
2.1 Preparations of bioactive compounds  122 
Humic Substances (HS) and fullerenol С60Оy(OH)x where у=2–4, х=22–24 (F) were used as 123 
bioactive compounds.  124 
The Gumat-80 preparation (Gumat, Russia) was produced by non-extracting treatment of coal 125 
with alkali (КОН, NaOH) (Levinsky 2000). Characteristics of the preparation are humic acids 126 
– 85 %, soluble potassium – 9 %, iron – 1 %, water – 5 %, and pH 8-9 in 1 % water solution. 127 
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The F was produced by fullerene-60 hydroxylation in nitric acid followed by the hydrolysis of 128 
the polynitrofullerenes (Goncharova et al. 2009; Isakova et al. 2011; Churilov et al. 2013). 129 
The F preparations were characterized with IR and photoelectron spectroscopies (Goncharova 130 
et al. 2009; Isakova et al. 2011; Juan et al. 2012). Fullerene-60 was preliminary synthesized 131 
by carbon helium high-frequency arc plasma at atmospheric pressure (Churilov et al. 2013). 132 
The fullerene content in carbon soot was about 12.6%. Fullerene mixture was extracted with 133 
toluene, and separated by liquid chromatography with turbostratic graphite (with interplanar 134 
distance 3.42 Å) as a stationary phase and toluene/hexane (4:6) mixture as a mobile phase.  135 
 136 
2.2 Bioluminescence enzymatic assay and experimental data processing 137 
Toxicity and antioxidant activity of HS and F were evaluated using bioluminescence 138 
enzymatic assay system, i.e. enzyme preparation, based on the coupled enzyme system 139 
NADH:FMN-oxidoreductase from Vibrio fischeri (0.15 a.u.) and luciferase from 140 
Photobacterium leiognathi, 0.5 mg ml-1 (Kuznetsov et al. 1996). The enzyme preparation was 141 
produced at the Institute of Biophysics SB RAS (Krasnoyarsk, Russia). Antioxidant activity 142 
of HS and F was assessed in water solutions of model oxidizers K3[Fe(СN)6] (potassium 143 
ferricyanide) and 1,4-benzoquinone.  144 
The chemicals used were: NADH from ICN, USA; FMN, and tetradecanal from SERVA, 145 
Germany; potassium ferricyanide of analytical grade from Khimreactiv, Russia; 1,4-146 
benzoquinone from Aldrich, USA; sodium chloride (NaCl) from Khimreactiv, Russia. 147 
To construct the enzyme system, 0.1 mg ml-1 enzyme preparation, 5∙10-4 M FMN, 4∙10-4 M 148 
NADH, and 0.002% tetradecanal solutions were used. The assay was performed in 0.05 M 149 
phosphate buffer (pH 6.8) at room temperature. 150 
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Measurements of bioluminescent intensity were carried out with bioluminometers BLM-3606 151 
(Nauka Special Design Bureau, Russia) and TriStar LB 941 (Berthold Technologies, 152 
Germany). Time-course of the bioluminescent intensity was recorded.  153 
Toxic effects of HS and F were evaluated by relative bioluminescent intensities, 
rel
HSI or 
rel
FI , 154 
respectively: 155 
 156 
contrHS
rel
HS III /  or  contrF
rel
F III /   (eq. 1) 157 
 158 
Here, Icontr and IHS or IF are maximal bioluminescent intensities in the absence and presence of 159 
HS or F, respectively.  160 
Antioxidant activity of bioactive compounds (HS and F). Bioluminescence kinetics curves of 161 
enzymatic assay system are presented in Figure 1. The HS were chosen here as a 162 
representative of bioactive compounds. The evaluation was carried out in model solutions of 163 
oxidizers (1,4-benzoquinone or potassium ferricyanide). To compare toxic effects of the 164 
bioactive substances (HS and F), the effective concentrations of oxidizers, EC50, (at Iox/Icontr = 165 
0.5) were determined. Here, 
contrI and OxI are bioluminescence intensities in the absence and 166 
presence of oxidizers, respectively. Values of Icontr and IOx are shown in Figure 1. Changes of 167 
bioluminescence kinetics under addition of HS are shown in Figure 1, too. 168 
Changes of Oxidative Toxicity (OxT) under exposure to HS or F were characterized with 169 
detoxification coefficients, DOxT :  170 
 171 
 DOxT= (T0.5)Оx / (T0.5)Оx+HS, or DOxT= (T0.5)Оx / (T0.5)Оx+F  (eq. 2) 172 
 173 
Here, (T0.5)Оx, (T0.5)Оx+HS, or (T0.5)Оx+F are bioluminescence delay periods in the oxidizer 174 
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solutions in the absence and presence of HS or F, respectively, Figure 1. Values of DOxT were 175 
determined at different HS or F concentrations. 176 
Values of DOxT >1 showed a decrease of OxT in oxidizer solutions under the exposure to HS 177 
or F, i.e. detoxification of the oxidizer solutions. Values of DOxT <1 showed a toxic effect of 178 
HS or F. 179 
Values of SD for DOxT did not exceed 0.1. The data for the calculations of DOxT were obtained 180 
in three parallel experiments with five samplings for all HS, F and control solutions. 181 
The DOxT values of HS were determined at different times of incubation with oxidizers: 0, 7, 182 
15, 50, 130, and 160 min. 183 
 184 
2.3 Luminol chemiluminescence assay 185 
Luminol from Sigma-Aldrich, Russia, potassium hydroxide (KOH) from Khimreactiv, 186 
Russia, 3% hydrogen peroxide solution (Н2О2) from Tula Pharmaceutical Factory, Russia, 187 
were used in chemiluminescence method. 188 
The 3% hydrogen peroxide solution (Н2О2) was applied to prepare the model peroxide 189 
solutions. Concentration of aqueous alkaline luminol was 10-4М. 190 
The chemiluminescence reaction was initiated by K3[Fe(CN)6] solution through TriStar LB 191 
941 bioluminometer injector system. Maximal chemiluminescence intensity was determined. 192 
Measurements of chemiluminescence intensity were performed in 25-40 replicates for all 193 
solutions; average and SD values were calculated, they did not exceed 0.1. 194 
Dependence of chemiluminescence intensity on H2O2 concentration was determined; it was 195 
used in the following experiments to evaluate concentrations of peroxide compounds in the 196 
solutions of HS or F. The peroxide content was plotted vs. concentrations of HS or F. To 197 
compare effects of HS and F, their effective concentrations decreasing chemiluminescence 198 
intensity by 50%, EC50, were determined. 199 
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 200 
3 Results 201 
3.1 Toxicity of bioactive compounds 202 
To compare the toxicity of HS and fullerenol (F), the dependencies of relative 203 
bioluminescence intensities Irel  on concentration of the compounds were determined. It is seen 204 
from Fig 2 that both HS and F demonstrate inhibition (toxic) effects (
rel
HSI < 1; 
rel
FI < 1), 205 
however their inhibiting concentration intervals differ. 206 
It should be noted that all experiments with “colored” solutions of HS and F excluded effect 207 
of ‘optic filter’ (Fedorova et al. 2007), and this effect did not skew the results the 208 
toxicological measurements.  209 
To compare toxicity of HS and F in water solutions, values of EC50 were determined using 210 
enzymatic bioluminescent assay (Table 1). 211 
Enzymatic assay revealed higher values of ЕС50 for F than HS, showing higher HS toxicity 212 
for enzymatic reactions. Probably nonrigid structure of HS, flexibility of the macromolecular’ 213 
fragments and functional groups provided their intervention to the enzyme-substrates binding 214 
in water solutions. Additionally, it is known that bioluminescence enzymatic reaction includes 215 
a peroxide compound (peroxyhemiacetal) as an intermediate (Nemtseva and Kudryasheva 216 
2007), hence, a decrease of peroxide content in HS solutions can be a reason of the inhibition 217 
of bioluminescence intensity of the enzymatic assay system. Following this suggestion, we 218 
used luminol chemiluminescent method to compare the peroxide contents (as representative 219 
of Reactive Oxygen Species, ROS) in the solutions of HS and F. Dependences of ROS 220 
content on HS or F concentrations were studied, a suppression of chemiluminescence signal 221 
was demonstrated, Fig.3. Concentrations of HS and F decreasing ROS content by 50%, ЕС50, 222 
were determined and presented in Table 1, second column. 223 
The Table shows that HS decrease amount of ROS more effectively than F (values of ЕС50 for 224 
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the chemiluminescence assay are 0.008 and 0.235 g L-1, respectively). This ability of HS is 225 
concerned with involvement of their redox chemical groups, decreasing the amount of 226 
peroxides in solutions, and hence, inhibiting the bioluminescence reaction. 227 
Inhibition and activation of bioluminescence signal by ROS was reported previously for 228 
bacterial and enzymatic assays (Remmel et al. 2003; Alexandrova et al. 2011); hydrogen 229 
peroxide was applied by the authors as a representative of ROS. 230 
Hence, the differences in toxic effects of HS and F on the enzymatic and chemiluminescence 231 
assay systems (Table 1, Figs 2-3) can be concerned with (1) flexibility of fragments and 232 
functional groups of HS, (2) their higher ability to decrease ROS content. These properties of 233 
HS might contribute to their antioxidant activity, as well. The following chapter 3.2 compares 234 
the antioxidant activity of HS and F. 235 
 236 
3.2 Antioxidant activity of bioactive compounds in solutions of oxidizers 237 
ROS content is directly concerned with Oxidative Toxicity (OxT) of the solutions. To monitor 238 
changes of OxT under exposure to bioactive compounds, HS and F, the bioluminescent 239 
enzymatic assay was applied. This assay is known to be specific to the group of oxidizers 240 
(Vetrova et al, 2007): in their presence, the bioluminescence delay period takes place (Figure 241 
1); it depends on concentration and redox potential of oxidizers, and evaluates quantitatively 242 
the OxT of the solutions (Kudryasheva and Tarasova, 2015). Preliminary, we determined C50 243 
in model solutions of organic and inorganic oxidizers (1,4-benzoquinone and potassium 244 
ferricyanide, respectively). Model oxidizers chosen are of high oxidative activity (standard 245 
redox potentials of 1,4-benzoquinone is 0.7 V, and this of ferricyanide is 0.36 V (Vanýsek 246 
1983), but differ in polar/apolar characteristics). The changes of OxT in the solutions exposed 247 
to HS and F were studied; values of DOxT   were calculated and compared. 248 
 249 
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(a) Effect of oxidizers on bioluminescence assay system 250 
Values of ЕC50 of the 1,4-benzoquinone and potassium ferricyanide were determined as 10-4 251 
M and 2∙10-5M, respectively. These values are close to those determined earlier (Tarasova et 252 
al. 2011; Tarasova et al. 2012). 253 
The ЕС50 values of the oxidizers were applied in the following experiments to evaluate the 254 
antioxidant activity of the bioactive compounds, HS and F. 255 
 256 
(b) Change of toxicity of oxidizer solutions under exposure to bioactive compounds 257 
Change of bioluminescence intensity of enzymatic assay in solutions of oxidizers was studied 258 
under variation of concentrations of HS or F. Low concentrations of HS or F which do not 259 
produce toxic effects (< 0.002 g L-1 for HS, or < 0.010 g L-1 for F Fig.2) have been chosen. 260 
Detoxification coefficients DOxT have been calculated according to eq.2 at different 261 
concentrations of HS and F. Detoxifying (antioxidant) effects (DOxT >1) of HS and F were 262 
found in solutions of organic (Fig. 4) and inorganic (Fig. 5) oxidizers. Detoxification 263 
coefficients of F presented in Fig. 4b and Fig.5b were determined previously (Sachkova et al. 264 
2017). 265 
The detoxifying effect of HS was found to depend on time of preliminary incubation with the 266 
oxidizers: only high incubation times (> 7 min) provided statistically significant antioxidant 267 
effect (DOxT >1), however, shorter incubation times did not. Two times of incubation (0 and 268 
50 min) were chosen for presentation in Figs 4a and 5a. The choice of 50 min incubation time 269 
was justified by saturation of detoxifying effect of HS at higher incubation times.  270 
Such peculiarity of HS behavior is concerned with their nonrigid and nonregular structure, 271 
which determines the importance of time-dependent diffusion processes in water solutions. 272 
The detoxifying effect of F did not depend on the incubation time.  273 
Table 2 presents intervals of detoxifying concentrations of HS and F, as well as maximal 274 
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values of DОхT. This Table and Figs 4, 5 show that the detoxifying concentrations of HS and F 275 
differ: the interval for F is moved to lower concentrations as compared to HS. In (Sachkova et 276 
al. 2017) a low-concentration effect of fullerenols was concerned with hormesis phenomenon 277 
(Calabrese 2015; 2014) that can be explained with structural effects of water media (Iavicoli 278 
et al. 2018; Zheng et al. 2017). Following this hypothesis, diffusion-dependent processes 279 
involving macromolecules of HS might prevent from aqua structuring, minimizing low-280 
concentration effects of HS. 281 
Antioxidant effect of HS is of ‘soft’ character: average values of DОхT  do not exceed 1.3 282 
(Table 2). This effect is similar in solutions of both organic and inorganic oxidizers. The latter 283 
means that the difference in polar/apolar characteristics of oxidizers is not important for HS. 284 
This difference appeared to be important for F; value of DОхT  is much higher in solutions of 285 
organic amphiphilic oxidizer: 2.0 and 1.3 for 1,4-benzoquinone and ferricianide, respectively, 286 
Table 2, Figs 4,5. Probably, hydrophobic interactions of the organic oxidizer in complex 287 
enzymes+F+1,4-benzoquinone solutions contribute to the catalytic activity of the fullerenol. 288 
Rigid structure of hydrophobic fragments in fullerene carcass of F nanoparticle might be 289 
important for such interactions.  290 
 291 
4 Conclusions 292 
Current study compares toxic and antioxidant effects of humic substances, natural detoxifying 293 
compounds, with fullerenol – a representative of a group of fullerene C-60 derivatives, a 294 
carbon nanosize structure, which is perspective in modern medical, biological and chemical 295 
technologies. Differences in toxic effects and antioxidant activity were attributed to structure 296 
of these compounds. Non-rigidity of humic macromolecules determines their diffusion 297 
restrictions, which result in higher toxicity and time-dependence of their antioxidant ability. 298 
The same property is probably responsible for unification of their antioxidant ability to 299 
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oxidizers of different hydrophilic/hydrophobic characteristics. On the contrary, antioxidant 300 
effect of fullerenol was found to depend on amphyphilic properties of oxidizers. However, 301 
further study of mechanisms of toxic and antioxidant effects of the bioactive compounds is of 302 
special applied and fundamental prospectivity. 303 
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Table 1 Effective concentrations of bioactive compounds, EC50, in enzymatic and 411 
chemiluminescence assays 412 
  413 
Bioactive 
compounds* 
ЕС50, g L-1 
Enzymatic 
bioluminescence assay 
Chemiluminescence assay 
HS 0.005 0.008 
F 0.108 0.235 
*
Bioactive compounds: HS – humic substanses; F – fullerenol 414 
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Table 2 Maximal values of DОхT and a range of detoxifying concentrations (DОхT >1) of 421 
bioactive compounds in model solutions of organic and inorganic oxidizers (1,4-422 
benzoquinone and К3[Fe(СN)6])  423 
Bioactive compound* 
Range of detoxifying concentrations, g L-1; 
Maximal value of DОхT  
1,4-benzoquinone К3[Fe(СN)6]  
 
HS (50 min incubation) 
4∙10-5 – 5∙10-3; 
1.3 
2∙10-6– 5∙10-3; 
1.3  
F 
10-14 – 5∙10-5; 
2.0 
10-14 – 2∙10-5; 
1.3  
*Bioactive compounds: HS – humic substanses; F – fullerenol 424 
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Figure captions 429 
 430 
Fig. 1 Bioluminescence kinetics in solution of a model oxidizer (Ox) and Humic Substances 431 
(HS) 432 
Fig. 2 Relative bioluminescence intensity Irel at different concentrations of bioactive 433 
compounds: humic substances (HS) and fullerenol (F). Enzymatic assay 434 
Fig. 3 Concentration of ROS vs. concentrations of bioactive compounds: humic substances 435 
(HS) and fullerenol (F). Chemiluminescence assay 436 
Fig.4 Detoxification coefficients DOxT vs. concentration of HS (a) and F (b) in solution of 1,4-437 
benzoquinone (C50 = 10
-4 M). Times of preliminary incubation of HS with 1,4 -438 
 benzoquinone are indicated in Fig. a 439 
Fig. 5 Detoxification coefficients DOxT vs. concentration of HS (a) and F (b) in solution of 440 
potassium ferricyanide (2·10-5 М). Times of preliminary incubation of HS with 441 
potassium ferricyanide are indicated in Fig. a 442 
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Fig.1. Bioluminescence kinetics in solution of a model oxidizer (Ox) and Humic
Substances (HS)
Click here to download Figure Fig.1.tif 
Fig.2 Relative bioluminescence intensity Irel at different concentrations of bioactive
compounds: humic substances (HS) and fullerenol (F). Enzymatic assay
Click here to download Figure Fig.2.tif 
Fig. 3 Concentration of ROS vs. concentrations of bioactive compounds: humic
substances (HS) and fullerenol (F). Chemiluminescence assay
Click here to download Figure Fig.3.tif 
Fig.4 Detoxification coefficients DOxT vs. concentration of HS (a) and F (b) in solution
of 1,4-benzoquinone (C50 = 10-4 M). Times of preliminary incubation of HS with 1,4 -
Click here to download Figure Fig.4.tif 
Fig. 5 Detoxification coefficients DOxT vs. concentration of HS (a) and F (b) in solution
of potassium ferricyanide (2*10-5 М). Times of preliminary incubation of HS with
Click here to download Figure Fig.5.tif 
